← Issue №15/ week of Oct 11, 2026/Esophagus/Reflux

Trends and Projections of Esophageal Cancer Incidence and Mortality in China, 1990 to 2050: An Analysis of the Global Burden of Disease Study 2023.

From GI Signals issue №15: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Esophagus/Reflux prospective cohort · Oct 6, 2026 · J Clin Gastro · IF 2.9

Trends and Projections of Esophageal Cancer Incidence and Mortality in China, 1990 to 2050: An Analysis of the Global Burden of Disease Study 2023.

Epidemiologyepidemiologyesophageal cancer
Clinical takeawayConsider intensified surveillance and targeted screening for high-risk populations in China, given the post-2020 rebound in esophageal cancer incidence.
What it foundEsophageal cancer age-standardized incidence rate (ASIR) in China declined from 28.23 to 11.45 per 100,000 from 1990 to 2023, with a rebound from 2020 to 2023 (APC: 4.86%; 95% CI: 3.01-6.73).
ContextConfirms long-term decline in esophageal cancer burden in China but highlights a recent rebound, challenging assumptions of continued progress.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Su P … Tian Z · Journal of Clinical Gastroenterology · IF 2.9 · PubMed ↗Permalink
← Read the whole of issue №15 Every paper GI Signals surfaces gets a page like this one. All issues